NCT06031311Not yet recruiting
Pulmonaryhypertension in Copd at Different Levels of Smoking
Clinical Characteristics and Predictors of Pulmonary Hypertension in COPD at Different Levels of Smoking
Assiut UniversityClinicalTrials.govdiagnostic test
Study focus
- Disease/Condition
- Pulmonary Hypertension
- Drug/Device/Intervention
- Echocardiography and HRCT
- Study type
- Observational
- Intervention type
- diagnostic test
Sponsor & location
- Primary sponsor
- Assiut University
Timeline & enrollment
- Phase
- N/A
- Start date
- Oct 01, 2023
- End date
- Dec 01, 2024
- Enrollment
- 138 participants
Primary outcome
Predictors of pulmonary hypertension in COPD patients
Summary
To identify Predictors of pulmonary hypertension in COPD patients and its relation to
 different levels of smoking
ICD-10 classifications
Primary pulmonary hypertensionOther secondary pulmonary hypertensionPulmonary heart disease and diseases of pulmonary circulationPulmonary heart disease, unspecifiedPulmonary valve disorders
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06031311
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for NCT06031311 through Pure Global AI's free database. This phase not specified trial is sponsored by Assiut University and is currently Not yet recruiting. The study focuses on Pulmonary Hypertension. Target enrollment is 138 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.